Medicines Co wins patent infringement suit against Mylan
October 27, 2014 at 20:26 PM EDT
Oct 27 (Reuters) - A U.S. court ruled Mylan Inc infringed the Medicines Co's patent on its blood-clot-inhibitor Angiomax, according to a court filing on Monday.
